Comparison of Outcomes from Tunnelled Femorally Inserted Central Catheters and Peripherally Inserted Central Catheters: a Propensity Score-matched Cohort Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 May 17

PMID 38760049

Authors

Craig McManus

Nicholas Mifflin

Renz Rivera

Sophie Vause

Ton Tran

Matthew Ostroff

Lorenza Harrowell

Steven Frost

Evan Alexandrou

Affiliations

Soon will be listed here.

Abstract

Objectives: To compare catheter-related outcomes of individuals who received a tunnelled femorally inserted central catheter (tFICC) with those who received a peripherally inserted central catheter (PICC) in the upper extremities.

Design: A propensity-score matched cohort study.

Setting: A 980-bed tertiary referral hospital in South West Sydney, Australia.

Participants: In-patients referred to the hospital central venous access service for the insertion of a central venous access device.

Primary And Secondary Outcome Measures: The primary outcome of interest was the incidence of all-cause catheter failure. Secondary outcomes included the rates of catheters removed because of suspected or confirmed catheter-associated infection, catheter dwell and confirmed upper or lower extremity deep vein thrombosis (DVT).

Results: The overall rate of all-cause catheter failure in the matched tFICC and PICC cohort was 2.4/1000 catheter days (95% CI 1.1 to 4.4) and 3.0/1000 catheter days (95% CI 2.3 to 3.9), respectively, and when compared, no difference was observed (difference -0.63/1000 catheter days, 95% CI -2.32 to 1.06). We found no differences in catheter dwell (mean difference of 14.2 days, 95% CI -6.6 to 35.0, p=0.910); or in the cumulative probability of failure between the two groups within the first month of dwell (p=0.358). No significant differences were observed in the rate of catheters requiring removal for confirmed central line-associated bloodstream infection (difference 0.13/1000 catheter day, 95% CI -0.36 to 0.63, p=0.896). Similarly, no significant differences were found between the groups for confirmed catheter-related DVT (difference -0.11 per 1000 catheter days, 95% CI -0.26 to 0.04, p=1.00).

Conclusion: There were no differences in catheter-related outcomes between the matched cohort of tFICC and PICC patients, suggesting that tFICCs are a possible alternative for vascular access when the veins of the upper extremities or thoracic region are not viable for catheterisation.

References

Ostroff M, Zauk A, Chowdhury S, Moureau N, Mobley C . A retrospective analysis of the clinical effectiveness of subcutaneously tunneled femoral vein cannulations at the bedside: A low risk central venous access approach in the neonatal intensive care unit. J Vasc Access. 2020; 22(6):926-934. DOI: 10.1177/1129729820969291. View

Brescia F, Pittiruti M, Ostroff M, Spencer T, Dawson R . The SIC protocol: A seven-step strategy to minimize complications potentially related to the insertion of centrally inserted central catheters. J Vasc Access. 2021; 24(2):185-190. DOI: 10.1177/11297298211036002. View

Pittiruti M, Celentano D, Barone G, DAndrea V, Annetta M, Conti G . A GAVeCeLT bundle for central venous catheterization in neonates and children: A prospective clinical study on 729 cases. J Vasc Access. 2022; 24(6):1477-1488. DOI: 10.1177/11297298221074472. View

Weber M, Himebauch A, Conlon T . Utilization of lateral exit sites for femorally inserted central catheters in pediatric patients: A case report and review of the literature. J Vasc Access. 2022; 25(1):323-326. DOI: 10.1177/11297298221099138. View

Joynt G, Kew J, Gomersall C, Leung V, Liu E . Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest. 2000; 117(1):178-83. DOI: 10.1378/chest.117.1.178. View

Bartoli A, Donadoni M, Quici M, Rizzi G, La Cava L, Foschi A . Safety of mid-thigh exit site venous catheters in multidrug resistant colonized patients. J Vasc Access. 2023; 25(6):1808-1814. DOI: 10.1177/11297298231188150. View

Rooden C, Tesselaar M, Osanto S, Rosendaal F, Huisman M . Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost. 2005; 3(11):2409-19. DOI: 10.1111/j.1538-7836.2005.01398.x. View

Parienti J, Mongardon N, Megarbane B, Mira J, Kalfon P, Gros A . Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med. 2015; 373(13):1220-9. DOI: 10.1056/NEJMoa1500964. View

Sharp R, Carr P, Childs J, Scullion A, Young M, Flynn T . Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study. BMJ Open. 2021; 11(7):e045895. PMC: 8258560. DOI: 10.1136/bmjopen-2020-045895. View

10.

Wan Y, Chu Y, Qiu Y, Chen Q, Zhou W, Song Q . The feasibility and safety of PICCs accessed via the superficial femoral vein in patients with superior vena cava syndrome. J Vasc Access. 2017; 19(1):34-39. DOI: 10.5301/jva.5000810. View

11.

Ostroff M, Moureau N, Pittiruti M . Rapid Assessment of Vascular Exit Site and Tunneling Options (RAVESTO): A new decision tool in the management of the complex vascular access patients. J Vasc Access. 2021; 24(2):311-317. DOI: 10.1177/11297298211034306. View

12.

Timsit J, Farkas J, Boyer J, Martin J, Misset B, Renaud B . Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest. 1998; 114(1):207-13. DOI: 10.1378/chest.114.1.207. View

13.

Patel P, Olmsted R, Hung L, Popovich K, Meddings J, Jones K . A Tiered Approach for Preventing Central Line-Associated Bloodstream Infection. Ann Intern Med. 2019; 171(7_Suppl):S16-S22. DOI: 10.7326/M18-3469. View

14.

Guillermo-Corpus G, Ramos-Gordillo J, Pena-Rodriguez J . Survival and Clinical Outcomes of Tunneled Central Jugular and Femoral Catheters in Prevalent Hemodialysis Patients. Blood Purif. 2018; 47(1-3):132-139. DOI: 10.1159/000494206. View

15.

Gorski L, Hadaway L, Hagle M, Broadhurst D, Clare S, Kleidon T . Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021; 44(1S Suppl 1):S1-S224. DOI: 10.1097/NAN.0000000000000396. View

16.

Annetta M, Marche B, Dolcetti L, Taraschi C, La Greca A, Musaro A . Ultrasound-guided cannulation of the superficial femoral vein for central venous access. J Vasc Access. 2021; 23(4):598-605. DOI: 10.1177/11297298211003745. View

17.

Buetti N, Marschall J, Drees M, Fakih M, Hadaway L, Maragakis L . Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022; 43(5):553-569. PMC: 9096710. DOI: 10.1017/ice.2022.87. View

18.

Zhang J, Tang S, Hu C, Zhang C, He L, Li X . Femorally inserted central venous catheter in patients with superior vena cava obstruction: choice of the optimal exit site. J Vasc Access. 2016; 18(1):82-88. DOI: 10.5301/jva.5000592. View

19.

Buetti N, Ruckly S, Souweine B, Mimoz O, Timsit J . Risk of infections in intravascular catheters in situ for more than 10 days: a post hoc analysis of randomized controlled trials. Clin Microbiol Infect. 2023; 29(9):1200.e1-1200.e5. DOI: 10.1016/j.cmi.2023.05.025. View

20.

Zhao L, Cao X, Wang Y . Cannulation of the superficial femoral vein at mid-thigh when catheterization of the superior vena cava system is contraindicated. J Vasc Access. 2019; 21(4):524-528. DOI: 10.1177/1129729819896473. View